Journal of Medical Screening

Papers
(The TQCC of Journal of Medical Screening is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States27
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis27
Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review26
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening21
Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa19
Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England15
Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues13
Couple screening for recessively inherited disorders13
Interval cancer audit and disclosure in breast screening programmes: An international survey12
Newborn screening for biliary atresia using direct bilirubin: An implementation science study12
Detection and significance of small and low proliferation breast cancer11
Introduction of one-view tomosynthesis in population-based mammography screening: Impact on detection rate, interval cancer rate and false-positive rate11
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review10
Lymphoproliferative disease detected by breast cancer screening10
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey9
Are screening practice ethics committees needed?9
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening9
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis9
HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial9
Age at breast cancer screening in women with intellectual disability8
Colonoscopy may be weak link in organised colorectal cancer screening programme with faecal immunochemical test8
Long-term colorectal cancer incidence in a post-endoscopic screening cohort, accounting for surveillance, by baseline polyp group, anatomic subsite, and sex8
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes7
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland7
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing6
Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment6
When primary prevention replaces screening6
Impact of cumulative experience on the quality of screening colonoscopy: A 13-year observational study5
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 20205
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms5
Wide variability in colorectal cancer screening uptake by general practitioner: Cross-sectional study5
Risk stratification in medical screening5
Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women4
Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic4
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada4
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study4
Artificial intelligence for triaging of breast cancer screening mammograms and workload reduction: A meta-analysis of a deep learning software3
Combining genetic and non-genetic risk factors to predict disease, and reporting the screening performance of risk models3
Primary care outreach and decision counseling for lung cancer screening3
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis3
The randomized trial of mammography screening that was not—A cautionary tale3
Estimating stage-specific sensitivity for cancer screening tests3
Trends in colorectal cancer screening in the United States, 2012 to 20203
Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement3
0.082365036010742